Cargando…
ETS-related gene (ERG) expression as a predictor of oncological outcomes in patients with high-grade prostate cancer treated with primary androgen deprivation therapy: a cohort study
OBJECTIVES: To determine whether ETS-related gene (ERG) expression can be used as a biomarker to predict biochemical recurrence and prostate cancer-specific death in patients with high Gleason grade prostate cancer treated with androgen deprivation therapy (ADT) as monotherapy. METHODS: A multicentr...
Autores principales: | Rezk, Mark, Chandra, Ashish, Addis, Daniel, Møller, Henrik, Youssef, Mina, Dasgupta, Prokar, Yamamoto, Hide |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429920/ https://www.ncbi.nlm.nih.gov/pubmed/30852544 http://dx.doi.org/10.1136/bmjopen-2018-025161 |
Ejemplares similares
-
Androgen deprivation therapy and Gleason grade: unravelling implications on survival
por: Scott, Michael, et al.
Publicado: (2019) -
Modulation of androgen receptor DNA binding activity through direct interaction with the ETS transcription factor ERG
por: Wasmuth, Elizabeth V., et al.
Publicado: (2020) -
Better Understanding the Timing Of Androgen Deprivation Trial Outcomes: Impacts of Prior Androgen Deprivation Therapy
por: Stensland, Kristian D, et al.
Publicado: (2022) -
The effect of continuous androgen deprivation treatment on prostate cancer patients as compared with intermittent androgen deprivation treatment
por: Ku, Ja Yoon, et al.
Publicado: (2015) -
Dual functions of SPOP and ERG dictate androgen therapy responses in prostate cancer
por: Bernasocchi, Tiziano, et al.
Publicado: (2021)